About this episode
After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J vaccine recipients, and Dr. Kavita Patel, a practicing physician and former health official in President Obama’s administration, considers the pause’s impact on vaccine supply, timeline goals, and vaccine hesitancy among Americans. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.